Drug
Khk4563
Khk4563: highest development phase Phase 2, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KHK4563 NCT01412736 | Phase 2 | Uncontrolled and Suspected Eosinophilic Asthma |
Latest
No recent events.
Follow Khk4563 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.